Osteodystrophy in Cholestatic Liver Diseases Is Attenuated by Anti-γ-Glutamyl Transpeptidase Antibody.

Osteodystrophy in Cholestatic Liver Diseases Is Attenuated by Anti-γ-Glutamyl Transpeptidase Antibody.

Cholestatic liver diseases exhibit higher levels of serum γ-glutamyl transpeptidase (GGT) and incidence of secondary osteoporosis. GGT has been identified as a novel bone-resorbing factor that stimulates osteoclast formation. The aim of this study was to elucidate the interaction of elevated GGT lev...

Full description

Bibliographic Details
Main Authors: Yusuke Kawazoe, Mutsumi Miyauchi, Atsuhiro Nagasaki, Hisako Furusho, Syunryo Yanagisawa, Chea Chanbora, Toshihiro Inubushi, Hideyuki Hyogo, Takashi Nakamoto, Keiko Suzuki, Sawako Moriwaki, Susumu Tazuma, Shumpei Niida, Takashi Takata
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4587927?pdf=render

Internet

http://europepmc.org/articles/PMC4587927?pdf=render

Similar Items